维持性血液透析并发尿路上皮癌的诊疗进展
被引量:1
摘要
维持性血液透析患者易并发各类恶性肿瘤,其中以泌尿系统肿瘤最多见。作者就维持性血液透析并发尿路上皮癌的诊疗进展做一综述,以供临床参考。
出处
《现代泌尿外科杂志》
CAS
2014年第2期136-139,共4页
Journal of Modern Urology
参考文献32
-
1刘苏来,安瑞华,刘瑛,俞秋霞,原劲杨,白玉凤,郭松.维持性血液透析合并尿路上皮癌患者临床特点及危险因素分析(附11例报告)[J].临床泌尿外科杂志,2012,27(10):750-752. 被引量:4
-
2刘苏来,安瑞华,俞秋霞,黄建文,白玉凤,原劲杨,王岩,王涌泉,韩惟青,刘景诗.血液透析并发膀胱尿路上皮癌临床特点及透析龄对其生存期的影响[J].现代泌尿外科杂志,2013,18(3):244-246. 被引量:4
-
3MAISONNEUVE P,AGODOA L,GELLERT R,et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study[J]. Lancet, 1999,354 (9173) : 93-99.
-
4CHUNG SD,HUANG KH,LAI MK,et al. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urina- ry tract urothelial carcinoma[J]. Am J Kidney Dis,2007,50(5).. 743-753.
-
5MATAS AJ, SIMMONS RL, KJELLSTRAND CM, et al. In- creased incidence of malignancy during chronic renal failure[J]. Lancet, 1975,1 (7912) .. 883-886.
-
6WU CF,CHANG PL,CHEN CS,et al. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma [J]. J Urol,2006,176(2) ..477-481.
-
7CORESH J,SELVIN E, STEVENS LA, et al. Prevalence of chronic kidney disease in the United States[J]. JAMA, 2007, 298(17) :2038-2047.
-
8KANG CH,CHEN CH,CHIANG PH. Primary urothelial carci- noma of the upper urinary tract in dialysis patients with 5-year follow-up[J]. Jpn J Clin Oncol,2010,40(3) .-241-246.
-
9SATOH S, TSUCHIYA N, HABUCHI T, et al. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis[J]. J UroI, 2005,174(5) : 1749-1753.
-
10CHANG CH, YANG CM, YANG AH. Renal diagnosis of chron- ic hemodialysis patients with urinary tract transitional cell carci- noma in TaiwanEJ]. Cancer, 2007,109(8) : 1487-1492.
二级参考文献28
-
1陈江华,何强,徐莹.维持性血液透析患者微炎症状态的认识与防治[J].中华肾脏病杂志,2005,21(2):117-118. 被引量:149
-
2彭燕,袁伟杰.血液透析患者免疫缺陷与感染产生的机制探讨[J].中国血液净化,2007,6(6):328-332. 被引量:10
-
3STEWART J, BUCCIANTI G, AGOGOA L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealan[J]. J Am Soc Nephrol, 2003,14:197-- 207.
-
4MAISONNEUVE P, AGODOA L, GELLERT R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study[J].Lan- cet, 1999, 354:93--99.
-
5MATAS A J, SIMMONS R L, KJELLSTRAND C M, et al. Increased incidence of malignancy during chronic renal failur[J]. Lancet, 1975, 1 : 883-- 886.
-
6CHEN K S, LAI M K, HUANG C C, et al. Urolog- ic cancers inuremic patients[J]. Am J Kidney dis, 1995, 25:694--700.
-
7TSENG S F, CHUANG Y C, YANG W C. Long- term outcome or radical cystectomy in ESDR patients with bladder urothelial carcinoma[J].Int Urol Neph- rol, 2011, 43:1067--1071.
-
8CHANGCH, YANGCM, YANGAH. Renal di- agnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwa[J]. Canc- er, 2007, 109:1487--1492.
-
9KANG C H, CHEN C H, CHIANG P H. Primary urothelial carcinoma of the upper urinary tract in dial- ysis patients with 5-year follow-up[J].Jpn J Clin On- col, 2010, 40:241--246.
-
10WUCF, CHANGPL, CHENCS, etal. The out- come of patients on dialysis with upper urinary tract transitional cell carcinoma[J].J Urol, 2006, 176: 477-481.
共引文献6
-
1刘苏来,安瑞华,俞秋霞,黄建文,白玉凤,原劲杨,王岩,王涌泉,韩惟青,刘景诗.血液透析并发膀胱尿路上皮癌临床特点及透析龄对其生存期的影响[J].现代泌尿外科杂志,2013,18(3):244-246. 被引量:4
-
2蒋志玲.维持性血液透析并发脑出血的危险因素分析[J].中国实用神经疾病杂志,2017,20(15):109-111. 被引量:15
-
3许长理,徐辉,周亚男,宋金起.维持性透析患者合并泌尿系肿瘤的临床研究进展[J].承德医学院学报,2019,36(1):72-75.
-
4罗玉,沈妍,齐玉婷.维持性血液透析合并结核患者的临床分析[J].当代医学,2019,25(6):81-83. 被引量:1
-
5李修明,宋殿宾,刘慧,马光,于满,王志勇.血液透析患者合并尿路上皮癌12例临床分析[J].现代肿瘤医学,2021,29(10):1732-1734. 被引量:3
-
6刘慧洁.维持血液透析患者肿瘤发生及其相关因素的探讨[J].中华肿瘤防治杂志,2018,25(S2):85-85. 被引量:4
同被引文献7
-
1姜春生,陈文梅,陈岚,王绍华,栾洁.维持性血液透析患者合并膀胱癌的诊治分析[J].中国临床医生杂志,2011,39(2):34-36. 被引量:5
-
2李蕾,孙威,夏京华.维持性血液透析患者合并膀胱癌血液透析的护理及干预[J].中国肿瘤临床与康复,2013,20(1):89-90. 被引量:11
-
3韩苏军,张思维,陈万青,李长岭.中国膀胱癌发病现状及流行趋势分析[J].癌症进展,2013,11(1):89-95. 被引量:413
-
4叶红,曹红娣,吴文慧,杨俊伟.维持性血液透析合并恶性肿瘤患者的临床特征分析[J].中国中西医结合肾病杂志,2014,15(4):336-337. 被引量:10
-
5田野.应重视化疗在肌层浸润性膀胱癌保留膀胱治疗中的作用[J].首都医科大学学报,2014,35(3):269-272. 被引量:9
-
6李珊珊.维持性血液透析患者合并膀胱癌手术治疗的护理分析[J].中国实用医药,2015,10(5):221-223. 被引量:4
-
7王杰,张有才.维持性血液透析患者并发恶性肿瘤的临床分析[J].中国社区医师(医学专业),2014,16(7):27-27. 被引量:2
-
1张军晖,许建军,陈晓,韩志友,王勇,管德林,高居忠.肾移植术后并发泌尿系统肿瘤6例报告并文献复习[J].肿瘤防治研究,2003,30(6):494-495. 被引量:2
-
2宫大鑫.“无痛性肉眼血尿”当心膀胱癌[J].医食参考,2016,0(4):21-21.
-
3李淑萍.对接受TURBt的泌尿系统肿瘤患者进行喉罩通气下全静脉麻醉的效果观察[J].当代医药论丛,2016,14(3):150-152.
-
4颜克钧,庄乾元.肾移植术后并发泌尿系统恶性肿瘤二例[J].中华器官移植杂志,2003,24(3):138-138.
-
5本期专题执行主编简介[J].四川大学学报(医学版),2012,43(1).
-
6血尿[J].医食参考,2016,0(8):27-27.
-
7谢立平,王云彬,秦杰.腹腔镜技术治疗泌尿系统肿瘤的现状与问题[J].现代泌尿外科杂志,2007,12(6):351-354. 被引量:2
-
8刘海涛.警惕中老年人“无痛性肉眼血尿”[J].家庭用药,2009(2):64-64.
-
9陈文.慢性马兜铃酸肾病与泌尿系统肿瘤[J].肾脏病与透析肾移植杂志,2005,14(6):543-544. 被引量:5
-
10陈文,谌贻璞,李安.慢性马兜铃酸肾病患者伴发泌尿系统肿瘤[J].中华肾脏病杂志,2004,20(1):15-17. 被引量:28